Home > National Drug Code (NDC) > Treatment Set TS333541

Treatment Set TS333541 - 49288-0666-3 - (Treatment Set TS333541)

Alphabetical Index


Drug Information of Treatment Set TS333541

Product NDC: 49288-0666
Proprietary Name: Treatment Set TS333541
Non Proprietary Name: Treatment Set TS333541
Active Ingredient(s): 20000; 2000; .01; .01    [AU]/mL; [BAU]/mL; g/mL; g/mL & nbsp;   Treatment Set TS333541
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS333541

Product NDC: 49288-0666
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS333541

Package NDC: 49288-0666-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0666-3)

NDC Information of Treatment Set TS333541

NDC Code 49288-0666-3
Proprietary Name Treatment Set TS333541
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0666-3)
Product NDC 49288-0666
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Treatment Set TS333541
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name AMBROSIA ARTEMISIIFOLIA POLLEN; FELIS CATUS HAIR; IVA ANNUA VAR. ANNUA POLLEN; JUNIPERUS ASHEI POLLEN
Strength Number 20000; 2000; .01; .01
Strength Unit [AU]/mL; [BAU]/mL; g/mL; g/mL
Pharmaceutical Classes Standardized Animal Hair Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Dander [Chemical/Ingredient],Allergens [Chemical/Ingredient],Salivary Proteins and Peptides [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS333541


General Information